|
NDC61570-0024-01
|
6505-01-390-8316
|
Usp Chlorthalidone Tablets |
Monarch Pharmaceuticals Inc
|
|
Quote
|
|
4911-33
|
6505-01-390-8328
|
Usp Atropine Sulfate Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-4911-33
|
6505-01-390-8328
|
Usp Atropine Sulfate Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
4921-33
|
6505-01-390-8337
|
Usp Epinephrine Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-4921-33
|
6505-01-390-8337
|
Usp Epinephrine Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
4928-33
|
6505-01-390-8416
|
Usp Calcium Chloride Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-4928-33
|
6505-01-390-8416
|
Usp Calcium Chloride Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
GLUCOTROL XL
|
6505-01-391-1079
|
Usp Glipizide Tablets |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NDC00049-1550-66
|
6505-01-391-1079
|
Usp Glipizide Tablets |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NDC00591-0844-01
|
6505-01-391-1079
|
Usp Glipizide Tablets |
Actavis Pharma, Inc.
|
|
Quote
|
|
GLUCOTROL XL
|
6505-01-391-1081
|
Usp Glipizide Tablets |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NDC00049-1560-66
|
6505-01-391-1081
|
Usp Glipizide Tablets |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NDC59762-0542-01
|
6505-01-391-1081
|
Usp Glipizide Tablets |
Greenstone Ltd
|
|
Quote
|
|
GLIPIZIDE ER
|
6505-01-391-1081
|
Usp Glipizide Tablets |
Greenstone Ltd
|
|
Quote
|
|
ZOSYN
|
6505-01-391-3788
|
Piperacillin Sodium And Tazobact |
American Cyanamid Co
|
|
Quote
|
|
NDC00206-8620-11
|
6505-01-391-3788
|
Piperacillin Sodium And Tazobact |
American Cyanamid Co
|
|
Quote
|
|
9791-01
|
6505-01-391-4419
|
Fat Emulsion Injection |
Kendall Mcgaw Laboratories
|
|
Quote
|
|
NDC00074-9791-01
|
6505-01-391-4419
|
Fat Emulsion Injection |
Kendall Mcgaw Laboratories
|
|
Quote
|
|
9791-01
|
6505-01-391-4419
|
Fat Emulsion Injection |
Kendall Mcgaw Laboratories
|
|
Quote
|
|
NDC00074-9791-01
|
6505-01-391-4419
|
Fat Emulsion Injection |
Kendall Mcgaw Laboratories
|
|
Quote
|
|
NDC52244-0404-10
|
6505-01-391-4612
|
Acrivastine And Pseudoephedrine |
Ucb Pharma, Inc.
|
|
Quote
|
|
NDC52244-0404-10
|
6505-01-391-4612
|
Acrivastine And Pseudoephedrine |
Ucb Pharma, Inc.
|
|
Quote
|
|
NDC00004-0239-09
|
6505-01-391-6108
|
Graniestron Hydrochloride Inject |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00004-0239-09
|
6505-01-391-6108
|
Graniestron Hydrochloride Inject |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00004-0239-09
|
6505-01-391-6108
|
Graniestron Hydrochloride Inject |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00487-9801-25
|
6505-01-391-6109
|
Ipratropium Bromide Inhalation S |
Nephron Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00378-6989-62
|
6505-01-391-6109
|
Ipratropium Bromide Inhalation S |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC49502-0685-26
|
6505-01-391-6109
|
Ipratropium Bromide Inhalation S |
Mylan Specialty L.p.
|
|
Quote
|
|
NDC00487-9801-25
|
6505-01-391-6109
|
Ipratropium Bromide Inhalation S |
Nephron Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00487-9801-25
|
6505-01-391-6109
|
Ipratropium Bromide Inhalation S |
Nephron Pharmaceuticals Corporation
|
|
Quote
|
|
CATAFLAM
|
6505-01-391-6112
|
Diclofenac Potassium Tablets |
Ciba
|
|
Quote
|
|
NDC00028-0151-01
|
6505-01-391-6112
|
Diclofenac Potassium Tablets |
Ciba
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC000338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corporation
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corporation
|
|
Quote
|
|
AFTER BITE
|
6505-01-392-6764
|
Ammonium Hydroxide Topical Solut |
Tender Corporation
|
|
Quote
|
|
06-1012
|
6505-01-392-6764
|
Ammonium Hydroxide Topical Solut |
Tender Corporation
|
|
Quote
|
|
NDC00536-1402-12
|
6505-01-392-8436
|
Hemorrhoidal Suppositories |
Rugby Group Inc
|
|
Quote
|
|
MYCELEX 7
|
6505-01-393-0433
|
Usp Clotrimazole Vaginal Cream |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC16500-0250-20
|
6505-01-393-0433
|
Usp Clotrimazole Vaginal Cream |
Talecris Biotherapeutics Holdings
|
|
Quote
|
|
NDC16500-0250-20
|
6505-01-393-0433
|
Usp Clotrimazole Vaginal Cream |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
2508
|
6505-01-393-0433
|
Usp Clotrimazole Vaginal Cream |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00472-0220-41
|
6505-01-393-0433
|
Usp Clotrimazole Vaginal Cream |
Watson Pharmaceuticals Inc.
|
|
Quote
|
|
200 PROOF GALLON
|
6505-01-393-1640
|
Usp Alcohol |
Aaper Alcohol and Chemical Company
|
|
Quote
|
|
NDC00037-5020-01
|
6505-01-393-2134
|
Torsemide Tablets |
Meda Pharmaceuticals, Inc
|
|
Quote
|
|
NDC00054-0077-25
|
6505-01-393-2134
|
Torsemide Tablets |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
NDC00603-6134-21
|
6505-01-393-2135
|
Torsemide Tablets |
Generics Bidco I, Llc
|
|
Quote
|
|
NDC00004-0262-49
|
6505-01-393-2136
|
Torsemide Tablets |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC53169-0102-60
|
6505-01-393-2136
|
Torsemide Tablets |
Roche Diagnostics Corporation
|
|
Quote
|
|
DEMADEX
|
6505-01-393-2136
|
Torsemide Tablets |
Roche Diagnostics Corporation
|
|
Quote
|
|
DEMADEX TABLETS
|
6505-01-393-2136
|
Torsemide Tablets |
Roche Diagnostics Corporation
|
|
Quote
|
|
NDC00004-0263-49
|
6505-01-393-2137
|
Torsemide Tablets |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC53169-0103-60
|
6505-01-393-2137
|
Torsemide Tablets |
Roche Diagnostics Corporation
|
|
Quote
|
|
DEMADEX
|
6505-01-393-2137
|
Torsemide Tablets |
Roche Diagnostics Corporation
|
|
Quote
|
|
DEMADEX TABLETS
|
6505-01-393-2137
|
Torsemide Tablets |
Roche Diagnostics Corporation
|
|
Quote
|
|
NDC00037-5001-01
|
6505-01-393-2138
|
Torsemide Tablets |
Meda Pharmaceuticals, Inc
|
|
Quote
|
|
NDC00004-0265-49
|
6505-01-393-2139
|
Torsemide Tablets |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC00004-0264-49
|
6505-01-393-2140
|
Torsemide Tablets |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
94-6100
|
6505-01-393-2140
|
Torsemide Tablets |
Defense Medical Standardization
|
|
Quote
|
|
ZEMURON
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Organon Inc
|
|
Quote
|
|
NDC63323-0426-05
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Elkins Telecommunications Llc
|
|
Quote
|
|
NDC00052-0450-15
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Organon Inc
|
|
Quote
|
|
NDC00409-9558-05
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Hospira, Inc.
|
|
Quote
|
|
659850.4
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Schering Plough, Sa
|
|
Quote
|
|
ESMERON 10MG/ML 10VIALES
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Schering Plough, Sa
|
|
Quote
|
|
8470006598504
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Schering Plough, Sa
|
|
Quote
|
|
NDC00052-0450-15
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Organon Inc
|
|
Quote
|
|
ZEMURON
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Organon Inc
|
|
Quote
|
|
ZEMURON INJECTION
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Organon Inc
|
|
Quote
|
|
NDC63323-0426-05
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Fresenius Kabi Usa Llc
|
|
Quote
|
